Beauty Health Co Quarterly Cost of Revenue in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Beauty Health Co quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q2 2024.
  • Beauty Health Co Cost of Revenue for the quarter ending June 30, 2024 was $49.7M, a 0.1% increase year-over-year.
  • Beauty Health Co Cost of Revenue for the twelve months ending June 30, 2024 was $244M, a 73.1% increase year-over-year.
  • Beauty Health Co annual Cost of Revenue for 2023 was $243M, a 107% increase from 2022.
  • Beauty Health Co annual Cost of Revenue for 2022 was $117M, a 43.6% increase from 2021.
  • Beauty Health Co annual Cost of Revenue for 2021 was $81.5M, a 57.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $244M $49.7M +$51K +0.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $244M $33M +$868K +2.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $243M $51.1M +$19.5M +61.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $223M $110M +$82.5M +301% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $141M $49.6M +$16.1M +48.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $125M $32.2M +$7.64M +31.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $117M $31.6M +$7.23M +29.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $110M $27.4M +$5.36M +24.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $105M $33.5M +$14.2M +73.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $90.3M $24.5M +$8.73M +55.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $81.5M $24.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 $22.1M +$8.47M +62.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $19.3M +$9.42M +95.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $15.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $13.6M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $9.84M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.